Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy.
Pradere, P
Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy. [electronic resource] - European journal of cancer (Oxford, England : 1990) 04 2017 - 308-309 p. digital
Publication Type: Case Reports; Letter
1879-0852
10.1016/j.ejca.2016.12.027 doi
Antibodies, Monoclonal, Humanized--adverse effects
Aspergillosis, Allergic Bronchopulmonary--chemically induced
Carcinoma, Renal Cell--drug therapy
Humans
Immunocompromised Host
Immunosuppressive Agents--adverse effects
Indoles--therapeutic use
Kidney Neoplasms--drug therapy
Lung Neoplasms--drug therapy
Male
Middle Aged
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Pyrroles--therapeutic use
Sunitinib
Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy. [electronic resource] - European journal of cancer (Oxford, England : 1990) 04 2017 - 308-309 p. digital
Publication Type: Case Reports; Letter
1879-0852
10.1016/j.ejca.2016.12.027 doi
Antibodies, Monoclonal, Humanized--adverse effects
Aspergillosis, Allergic Bronchopulmonary--chemically induced
Carcinoma, Renal Cell--drug therapy
Humans
Immunocompromised Host
Immunosuppressive Agents--adverse effects
Indoles--therapeutic use
Kidney Neoplasms--drug therapy
Lung Neoplasms--drug therapy
Male
Middle Aged
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Pyrroles--therapeutic use
Sunitinib